A landmark announcement by the National Institute of Health Care and Excellence (NICE) outlines details of who will be offered hybrid closed-loop technology in England and Wales.

We are aware of reports regarding supply issues of insulin in the UK. Some of these reports are of insulins that are being discontinued and some are where there is a temporary shortage. Here’s the ...

Devastating diabetes complications costs the UK healthcare system £6.2 billion a year, which highlights not just the seriousness of diabetes but also the importance of getting the right care to people ...

In this first episode, Roxy Horner and Katie Lamb chat about their experiences of living with diabetes, from pregnancy to tech, and everything in between. In this episode, Georgia Weston, Sam Dottin ...

Congratulations to Diabetes UK-funded researcher Professor Roy Taylor, who has been awarded an MBE in the New Year Honours list, recognising his world-leading work in diabetes research.

The first ever immunotherapy for type 1 diabetes has been licensed for use in the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) has decided teplizumab, also known as Tzield, is ...

We take a look at some of the exciting diabetes research developments announced in October, and what the findings could mean for people living with or affected by diabetes.

We are calling for access to earlier care for people with diabetes, and a renewed government focus on preventing type 2 diabetes, following a new report that reveals the NHS is in a “critical ...

Our new data shows that an urgent intervention is needed in diabetes care and type 2 diabetes prevention to lower the number of people living with diabetes or prediabetes. Save for later Page saved!

The Shift-Diabetes research team at King’s College London is working to understand more about how night work influences diet and blood sugar levels in people living with type 2 diabetes. Our ...

The NHS had been facing supply issues with glucagon-like peptide receptor agonists (GLP-1 RAs, or GLP-1 analogues), a range of drugs used for managing blood glucose levels in people with type 2 ...

Our analysis has revealed that the number of children receiving treatment for type 2 diabetes in Paediatric Diabetes Units in England and Wales has increased by over 50%. We’re calling on the ...